Agilent Technologies, Inc. (A) Shares Bought by Advisor Partners LLC
Advisor Partners LLC boosted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 14.8% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 7,737 shares of the medical research company’s stock after buying an additional 1,000 shares during the period. Advisor Partners LLC’s holdings in Agilent Technologies were worth $459,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently made changes to their positions in A. Boston Advisors LLC boosted its stake in shares of Agilent Technologies by 27.7% in the first quarter. Boston Advisors LLC now owns 40,302 shares of the medical research company’s stock worth $2,131,000 after buying an additional 8,730 shares during the period. Coastline Trust Co purchased a new stake in shares of Agilent Technologies during the first quarter worth about $277,000. DnB Asset Management AS boosted its stake in shares of Agilent Technologies by 14.1% in the first quarter. DnB Asset Management AS now owns 40,449 shares of the medical research company’s stock worth $2,139,000 after buying an additional 5,000 shares during the period. Cullinan Associates Inc. boosted its stake in shares of Agilent Technologies by 26.9% in the first quarter. Cullinan Associates Inc. now owns 50,450 shares of the medical research company’s stock worth $2,667,000 after buying an additional 10,700 shares during the period. Finally, Cribstone Capital Management LLC boosted its stake in shares of Agilent Technologies by 2.3% in the first quarter. Cribstone Capital Management LLC now owns 2,359 shares of the medical research company’s stock worth $125,000 after buying an additional 54 shares during the period.
Shares of Agilent Technologies, Inc. (A) opened at 60.14 on Wednesday. The firm has a market capitalization of $19.33 billion, a PE ratio of 33.81 and a beta of 1.30. The stock has a 50 day moving average price of $60.08 and a 200 day moving average price of $55.15. Agilent Technologies, Inc. has a 12-month low of $42.92 and a 12-month high of $61.84.
Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Monday, May 22nd. The medical research company reported $0.58 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.48 by $0.10. The business had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.05 billion. Agilent Technologies had a return on equity of 16.49% and a net margin of 13.41%. The business’s revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.44 earnings per share. Analysts predict that Agilent Technologies, Inc. will post $2.23 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 26th. Stockholders of record on Monday, July 3rd were given a dividend of $0.132 per share. The ex-dividend date of this dividend was Thursday, June 29th. This represents a $0.53 annualized dividend and a dividend yield of 0.88%. Agilent Technologies’s dividend payout ratio is presently 29.78%.
A number of analysts recently issued reports on the company. Barclays PLC reissued a “buy” rating and issued a $67.00 target price on shares of Agilent Technologies in a research report on Wednesday, July 19th. Wells Fargo & Company raised Agilent Technologies from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $42.92 to $60.73 in a research report on Wednesday, July 12th. Deutsche Bank AG reaffirmed a “buy” rating and set a $66.00 price objective on shares of Agilent Technologies in a research report on Thursday, June 22nd. BidaskClub raised Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research report on Sunday. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Agilent Technologies in a research report on Monday, July 10th. Two investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Agilent Technologies has a consensus rating of “Buy” and an average target price of $60.12.
In other news, CFO Didier Hirsch sold 5,710 shares of the business’s stock in a transaction that occurred on Thursday, June 1st. The stock was sold at an average price of $60.60, for a total transaction of $346,026.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Michael R. Mcmullen sold 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $59.86, for a total value of $2,993,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 112,608 shares of company stock valued at $6,737,509.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.